Validation of the Turkish Version of the S3-NIV Questionnaire
Reliability and Validity of the Turkish Version of the Severe Respiratory Insufficiency Questionnaire for Non-Invasive Ventilation (S3-NIV)
1 other identifier
observational
120
1 country
1
Brief Summary
This study aims to evaluate the psychometric properties, including reliability and validity, of the Turkish version of the Severe Respiratory Insufficiency Questionnaire for Non-Invasive Ventilation (S3-NIV). The S3-NIV is a specific tool designed to assess difficulties and compliance in patients receiving home non-invasive ventilation. A total of 120 stable patients using home NIV for at least 3 months will be enrolled across multiple centers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2026
CompletedStudy Start
First participant enrolled
May 21, 2026
CompletedFirst Posted
Study publicly available on registry
May 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
May 28, 2026
May 1, 2026
5 months
May 20, 2026
May 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Internal Consistency and Construct Validity of the Turkish S3-NIV
Evaluated using Cronbach's alpha coefficient for internal consistency and Confirmatory/Exploratory Factor Analysis (CFA/EFA) to confirm the structural validity of the 11-item scale.
Baseline (Day 0)
Secondary Outcomes (1)
Test-Retest Reliability
14 to 15 days after baseline
Study Arms (1)
Home NIV Patients
Patients with chronic respiratory failure who have been using home non-invasive ventilation (NIV) for at least 3 months and are in a clinically stable phase.
Interventions
An 11-item self-administered questionnaire designed to evaluate the difficulties and compliance of patients using home non-invasive ventilation (NIV).
Eligibility Criteria
Adult patients with chronic respiratory failure who are followed up in the outpatient clinic and have been using a home non-invasive ventilation (NIV) device for at least 3 months.
You may qualify if:
- Diagnosed with chronic respiratory failure requiring home non-invasive ventilation (NIV).
- Using a home NIV device for at least 3 months.
- Being in a clinically stable phase (no exacerbation or hospitalization in the last 1 month).
- Able to understand and answer the questionnaire.
- Provided written informed consent.
You may not qualify if:
- Acute respiratory failure or clinical instability.
- Severe cognitive impairment or psychiatric disorders preventing reliable communication.
- Active malignancy or terminal illness with a short life expectancy.
- Refusal to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, 34854, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ipek Ozmen, Prof.
Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist, PhD (c)
Study Record Dates
First Submitted
May 20, 2026
First Posted
May 27, 2026
Study Start
May 21, 2026
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
May 28, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
A decision on sharing individual participant data (IPD) has not yet been made. Data sharing may be considered upon reasonable request to the principal investigator after the publication of the study results.